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ABSTRACT
Background: For too long we have been ‘‘stuck’’ in old perspectives that have hampered the
advance of knowledge. In part, this is related to the challenges that people have in unlearning
misinformation. Aim: To address the need for an upgrade in the eating disorders field. Method: To
assist with replacing outdated and inaccurate ideas with new data, this lecture reviewed novel
approaches to eating disorders that engage scientists and clinicians from diverse fields to approach
questions about aetiology and treatment of eating disorders through new lenses. This forward-
looking lecture outlined critical questions that need to be addressed to move the field forward and
strategies for engaging scientists from different fields. Results: Leading-edge findings on genetics,
intestinal microbiota, and neuroscience are reviewed. Conclusions: This review encourages the
integration of new evidence-based knowledge to form the backbone of our understanding of and






The challenge of unlearning
The science of eating disorders has been hampered by
decades of misunderstanding and misconceptions about
the illnesses. Both lay and academic opinions have
perpetuated myths about the aetiology of eating
disorders, their treatment, and prospects for recovery.
As educators, it is critical that we move away from
teaching outdated information about eating disorders.
Emerging clinicians and researchers deserve fresh, evi-
dence-based knowledge so that they can approach
individuals with eating disorders and their families
unburdened by erroneous information that can hinder
detection and engagement in treatment. Since repeat-
ing erroneous myths only serves to solidify the associ-
ations in people’s minds, this lecture focused on a path
forward for introducing novel scientific findings that
engage researchers from a wide variety of disciplines in
order to advance the field.
Unlearning is challenging for humans. False beliefs,
once learned, become sticky and are resistant to
extinction. One of the most damaging examples in
recent medicine is the fallacious association between
vaccines and autism (1), which even after having been
retracted from the scientific literature and deemed
fraudulent (2), has continued to garner significant
momentum from parents and public figures (3–5),
resulting in outbreaks of diseases that had been
eradicated by universal vaccine policies (6,7). We face a
similar stickiness in the eating disorders field and require
broad, data driven, and coordinated approaches to
change public and medical opinion.
Introducing new knowledge by addressing
critical questions
One way to begin to change opinion is to determine what
the critical questions in the field are that need to be
addressed through new science. These can be new
questions or old questions that have been overlooked or
evolved into untested assumptions about eating dis-
orders. Four basic critical questions were addressed in this
lecture: aetiological continuum, risk prediction, tipping
point, and the fourth dimension: time.
Aetiological continuum
For decades we have assumed that the behaviours and
thought processes that we call ‘‘disordered eating’’ such
as dieting, overeating, body dissatisfaction, and drive for
thinness lie on an aetiological continuum with the
diagnosable eating disorders such as anorexia
nervosa (AN), bulimia nervosa (BN), and binge eating
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disorder (BED). In research on all three disorders,
researchers commonly broaden inclusion criteria in
their study populations in order to boost statistical
power (8). In some instances, the broadening is mild and
only extends to subthreshold conditions (9–11). In other
instances the relative rarity of threshold and subthres-
hold cases forces researchers to study these phenotyp-
ically similar phenomena such as body dissatisfaction
which may or may not be aetiologically related to AN,
BN, or BED. Much of what we know in the field comes
from samples defined by these presumably related
phenomena. If in fact we find, for example through
genetic studies, that individuals who harbour these
traits, but do not have threshold eating disorders are
aetiologically distinct, we will have to revisit the conclu-
sions that we have drawn in the field based on samples
defined in that way. This does not mean that these
phenomena are unimportant to study; it will simply
mean that they do not represent continuous traits that
at the extreme ends of the distribution define eating
disorders. Rather, traits such as body dissatisfaction may
exist in the population from mild to severe and traits
such as AN may exist in the population from mild to
severe, but the two continua may be aetiologically
distinct but linked by superficial phenotypic similarity.
Risk prediction
Imagine a scenario in which a group of 12-year old girls
and a boys’ wrestling team decided to go on a diet on a
Monday. The girls did so ostensibly because their
teacher was dieting and encouraged healthful eating
and weight control in her class; the boys did so to be
able to wrestle in a lower weight class. What happened
after the initiation of the diet in these children is
functionally a biological and psychological black box.
Discovering what occurs in that black box both bio-
logically and psychologically is a critical question to be
answered.
By Friday, the majority of the dieting kids were fed up
with the diet. Most of the class went out for pizza and ice
cream and gave up the quest for energy restriction. For a
small percentage, that fairly brief exposure to negative
energy balance (i.e. less energy expended than con-
sumed) tripped a switch and unleashed an urge to
transgress their satiety boundary and compensate for
the under-consumption of energy throughout the week.
Breaking the diet and overeating became the first step in
loss of control eating and repeat dieting could make the
satiety boundary become increasingly pale and ignor-
able. For a very small percentage of the girls and boys,
the diet brought an unpredictable sense of calm. Those
kids might have been the ones who were particularly
anxious and irritable at baseline, whose biology had a
paradoxical reaction to food deprivation. For them,
rather than increasing their irritability and discomfort,
negative energy balance relieved them of their inner
dysphoria. For them, starvation was reinforcing, and the
black box represented their unusual response to starva-
tion and the lure that drew them into the path of AN.
The question for the field to answer is, ‘‘what are the
mechanisms in the black box that lead each of those
groups of children to respond to negative energy
balance in the way that they do?’’
Tipping point
A third critical question is, ‘‘What is the tipping point for
developing AN, BN, and BED?’’ As we have heard
frequently, many individuals go on a weight loss diet,
but only a small percentage of them ever develop AN.
Likewise, episodes of overeating are nearly ubiquitous in
the developed world, but only a small percentage of
individuals go beyond overeating to the point of binge
eating and feeling out of control. Our science must
address what the critical factors are that characterize
these tipping points. Factors such as genetics, stress
reactivity, emotion dysregulation, infection, hormones,
the gut microbiota, gut peptides, and co-morbid psy-
chopathology may all play a role in defining the tipping
point into pathology.
The fourth dimension
As a field, we have neglected time. Our studies of risk
factors have commonly viewed all time points before the
onset of illness monotonically. Although methodologic-
ally challenging, it is essential that we infuse our risk
factor research with a developmental perspective. That
which acts as a risk factor at age 12 may not be a risk
factor at age 6 or 18. Failing to allow for developmental
heterogeneity can lead to overlooking significant find-
ings and lead to false conclusions. A valuable example is
the now classic twin studies by Klump et al. (12,13) who
identified genetic factors that contributed to variance in
liability to eating disorders after, but not before puberty.
Had they only studied their pre-pubertal twins, we might
have overlooked the role of genetics in eating disorders
aetiology.
How to address these critical questions
Reducing isolationism
The eating disorders field has been an island. We are a
small field and we have not been gregarious in engaging
external scientists in our work. We need an infusion of
new ideas and new scientists in order to bring the field
into the 21st century.
What makes eating disorders intriguing?
Part of the way we entice others into studying eating
disorders is to educate them about the intriguing facets of
eating disorders. The eating disorder phenotypes are
intriguing as the represent fundamental dysregulation of
behaviours that are essential for life. Being complicit in
attributing their cause to will power, stubbornness, and
vanity has repelled scientists who may be interested in
more fundamental and life-essential questions. The
bottom line is that treatment outcome is unacceptably
poor, especially for AN. We have no effective medications
for AN, and only one medication for BN (fluoxetine) and
one for BED (lisdexamphetamine), that have been
approved by the United States Food and Drug Adminis-
tration, neither of which offers long-term cure. The
discovery of new biology may yield new ‘‘druggable
targets’’ for each of these disorders, and understanding
their biology has widespread understanding not just for
the eating disorders, but also for co-morbid psychiatric
conditions and appetite, weight, and metabolic
dysregulation.
Anorexia nervosa
AN is intriguing to those outside of our field because of
the paradoxical reaction to starvation. For individuals
prone to AN, starvation is reinforcing, anxiolytic, and
even euphorigenic (14,15). Activity is more reinforcing
than food (16,17). Satiety is unpleasant (18). Fats are
aversive (19,20). Clinical experience verifies that refeed-
ing is agony and feels terrible. Finally, acutely ill
individuals with AN do not exhibit classic sickness
behaviours characteristic of the presence of inflamma-
tory processes (21,22). Each of these is in stark contrast
to the majority of individuals in the world who regularly
battle with the opposite tendencies in their quest for
weight loss.
Bulimia nervosa
BN is intriguing, as self-induced vomiting is highly
heritable (70%) (23). Why this should be the case is
not entirely clear. It is a reliably measured phenotype,
which could contribute to the high heritability estimate;
however, it is conserved across species (birds do it; wolves
do it), and the ability to self-induce vomiting varies across
the human population. Most individuals despise vomit-
ing, yet individuals with BN report it to be both negatively
reinforcing (i.e. removes the adverse consequences of a
binge) and positively reinforcing (i.e. euphorigenic)
(24,25). We have not yet succeeded in developing
animal models of self-induced vomiting, as many of our
favourite lab animals (i.e. rats) are non-emetic.
Binge eating disorder
BED has attracted considerable press since making its
way into the DSM-5 and it too holds intrigue for
scientists outside of the eating disorders field. Humans
have variable appetite responses to stress. We all know
people who eat more when stressed, do not eat at all
when stressed, or whose appetites seem unphased by
stress (26). Why this is the case remains unknown. Some
people find that negative emotions trigger binge
episodes and to most people this is intuitive, but for
others positive emotions can set them off (27). Both
impulse dyscontrol (28) and aberrant reward responses
have been implicated in BED (29), but we do not know
how and whether these systems interact. Finally, the
circadian dysregulation in BED is apparent to clinicians
(30,31). People with the disorder tend not to eat
breakfast and say their stomachs only wake up after
noon. Binge eating is often confined to the afternoon
and evening hours and BED and night eating syndrome
share some genetic factors (32). That an out of sync
biological clock may contribute to BED is an intriguing
hypothesis worthy of exploration.
Together these idiosyncratic characteristics render
eating disorders truly fascinating phenotypes and ones
to which scientists from a range of disciplines could
meaningfully contribute.
Genetics
Where have we been?
The genetics of eating disorders got off to a slow start in
part due to the fact that few believed that genes played
a role. We no longer have to emphasize that eating
disorders run in families and that twin studies have
documented considerable heritability for AN, BN, and
BED (33). Telling patients that genes are involved now
flows freely from clinicians’ mouths when discussing the
ubiquitous question of, ‘‘Why me?’’ even though we
have not yet identified the specific genes implicated in
risk for these disorders.
State of the science
Like much of psychiatric genetics, we wallowed through
the dark years of candidate gene and linkage studies,
demonstrating considerable hubris in believing that we
could choose one from 23,000 genes that might play a
role in a complex disorder like AN or BN using minute
sample sizes. Millions of dollars later, we had little to
show. With the advent of genome-wide association
studies (GWAS), the field has burgeoned with promise.
Schizophrenia is the poster child for psychiatric gen-
omics and has illustrated remarkably how increasing
sample size yields fruit. In their initial GWAS with 3000
cases (34), the schizophrenia consortium identified no
significant loci for their disorder. Two years later,
reaching a sample size of 9000, five new significant
loci were announced showing that sample size matters
in psychiatric genomics (35). Subsequent publications
raised the ante: 14,000 cases yielded 22 loci (36); and
now with 34,000 cases, this group has identified 108 loci
for schizophrenia which represent a rich search space for
drilling down into the biology of these genes to under-
stand how they influence risk for schizophrenia (37).
Two GWAS of AN have been published, and both
represent efforts similar to the initial schizophrenia foray
into GWAS. Both Wang et al. (1033 cases) (38) and
Boraska et al. (2907 cases) (39) failed to identify
significant hits. However, sign tests in the Boraska
study strongly suggest that increasing sample size will
lead to a similar discovery trajectory as that witnessed in
schizophrenia. Indeed serious global efforts are currently
underway to massively increase sample size for AN, and
BN and BED will follow.
Success in this area has the potential to revolutionize
our understanding of risk, prevention, and treatment of
eating disorders.
Intestinal microbiota
Knowledge on the role that the gut microbiota plays in
obesity, is a natural lead in to the possibility that
intestinal bugs could play a role in AN (40). This novel
approach has its sceptics; however, recall the revolu-
tionary Helicobacter pylori story which also attracted
doubters (41,42). The discovery that peptic ulcers were
not just caused by stress, but by a bacterium, changed
the world, and enabled individuals with ulcers to
experience cure rather than long-term partial symptom
management, prolonged pain, and quality of life decre-
ments. Although it is unlikely that we will discover a
similar paradigm-altering bug in AN, exploring the role
of the intestinal microbiota as an adaptation to pro-
longed starvation may indeed lead us to adjunct
treatments that make refeeding less distressing and
uncomfortable to patients and equalize fat distribution
during weight restoration.
Mounting evidence suggests that the intestinal
microbiota regulate key features of AN, including
weight regulation, energy metabolism (43), anxiety,
and depression (44), providing a strong rationale for
exploring the role of gut microbes in AN. Yet there has
been limited research to date, none of which has
explored the functional role of the intestinal microbiota
in the maintenance of and recovery from AN (45–48).
The existing literature on the gut–brain axis evokes a
model in which changes in gut microbial communities
associated with extreme weight loss may perpetuate
and contribute to AN via effects on weight and mood,
but further research is needed to define and understand
the alterations and functional effects of AN intestinal
microbiotas on adiposity and behaviour. This research is
key to designing microbiota-modulating treatment
strategies (e.g. promotion or elimination of specific
bacterial taxa), which could improve the psychological
and physical treatment experience of patients and
would comprise a significant therapeutic advance in
treatment of AN.
Neuroscience
Advances in the neuroscience of eating and appetite
could fill an entire lecture; however, this lecture
showcased one series of investigations that together
with other parallel endeavours may piece together the
complex interconnected and partially redundant net-
works in the brain that control the central behaviours of
feeding.
Jennings and Stuber (49–51) have focused on an area
of the brain called the bed nucleus of the stria terminalis
or the BNST. The BNST GABA neurons have a cell body
and a long strand with branched synapses that transmit
electrical signals from the BNST into the lateral hypo-
thalamus. Stuber and his team stimulated those syn-
apses’ optogenetics. They used genetically engineered
proteins from algae that are sensitive to light and
genetically engineered viruses to deliver them into the
brains of mice. Those proteins then get expressed only in
the BNST cells, including in the synapses that connect to
the hypothalamus. They then implant fibre-optic cables
in the brains of these specially bred mice, and shine light
through the cables and onto BNST synapses. A video of
this experiment shows what happens when light hit the
BNST of mice who had been well fed and under normal
conditions would have been indifferent to the presence
of food. As soon as the light hit BNST synapses, the mice
began to eat the high fat food voraciously even though
sated. As soon as the light was turned off, the eating
stopped. Repeat times four. This powerful illustration is
just a glimpse into the rich work being done on this
pathway, and together with similar research on other
brain networks, will start to piece together the complex-
ities not only of normal feeding behaviour but also of
the aberrant processes that characterize eating disorder
such as eating in the absence of hunger and not eating
in the presence of starvation.
Conclusion and realities
Recently, the international Academy for Eating Disorders
along with several advocacy organizations crafted ‘‘nine
truths‘‘ (52) about eating disorders to guide stakeholders
toward a more contemporary understanding of the
realities of the illnesses. Table 1 presents these truths,
which have now been translated into several languages.
The goal is for these truths to form the foundation for
contemporary thinking about eating disorders.
A valuable way forward is to engage a broad array of
scientists and clinicians to think about eating disorders
in new ways and to create previously unimaginable
synergies that will lead to new discoveries in the field.
AN remains the most lethal of all psychiatric disorders.
Suicide is significantly elevated in individuals with AN,
BN, and BED. Quality of life is seriously impaired and
subsequent generations suffer. New methods coupled
with open minds present the opportunity of enhanced
understanding, prevention, and treatment of these
pernicious illnesses.
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